Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 181

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain

Open access
Bandieri, Elena, Romero, Marilena, Ripamonti, Carla Ida, Artioli, Fabrizio, Sichetti, Daniela, Fanizza, Caterina, Santini, Daniele, Cavanna, Luigi, Melotti, Barbara, Conte, Pier Franco, Roila, Fausto, Cascinu, Stefano, Bruera, Eduardo, Tognoni, Gianni, Luppi, Mario, the Early Strong Opioid Treatment Study Investigators·2016·Journal of Clinical Oncology

Abstract

Purpose: The WHO guidelines on cancer pain management recommend a sequential three-step analgesic ladder. However, conclusive data are lacking as to whether moderate pain should be treated with either step II weak opioids or low-dose step III strong opioids. Patients and Methods: In a multicenter, 28-day, open-label randomized controlled study, adults with moderate cancer pain were assigned to receive either a weak opioid or low-dose morphine. The primary outcome was the number of responder patients, defined as patients with a 20% reduction in pain intensity on the numerical rating scale. Results: A total of 240 patients with cancer (118 in the low-dose morphine and 122 in the weak-opioid group) were included in the study. The primary outcome occurred in 88.2% of the low-dose morphine and in 57.7% of the weak-opioid group (odds risk, 6.18; 95% CI, 3.12 to 12.24; P < .001). The percentage of responder patients was higher in the low-dose morphine group, as early as at 1 week. Clinically meaningful (≥ 30%) and highly meaningful (≥ 50%) pain reduction from baseline was significantly higher in the low-dose morphine group (P < .001). A change in the assigned treatment occurred more frequently in the weak-opioid group, because of inadequate analgesia. The general condition of patients, which was based on the Edmonton Symptom Assessment System overall symptom score, was better in the morphine group. Adverse effects were similar in both groups. Conclusion: In patients with cancer and moderate pain, low-dose morphine reduced pain intensity significantly compared with weak opioids, with a similarly good tolerability and an earlier effect.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2015.61.0733

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 181

Metadata

Authors
Bandieri, E., Romero, M., Ripamonti, C. I., Artioli, F., Sichetti, D., Fanizza, C., Santini, D., Cavanna, L., Melotti, B., Conte, P. F., Roila, F., Cascinu, S., Bruera, E., Tognoni, G., Luppi, M., & the Early Strong Opioid Treatment Study Investigators
Venue
Journal of Clinical Oncology
Published
2016-02-10
Volume
34
Issue
5
Pages
436-442
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2189982580
Cited by
181
References
3
FWCI
19.30
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain. https://app.cochat.ai/papers/10.1200/jco.2015.61.0733
The paper
Bandieri, E., Romero, M., Ripamonti, C. I., Artioli, F., Sichetti, D., Fanizza, C., Santini, D., Cavanna, L., Melotti, B., Conte, P. F., Roila, F., Cascinu, S., Bruera, E., Tognoni, G., Luppi, M., & the Early Strong Opioid Treatment Study Investigators. (2016). Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2015.61.0733

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.